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Abstract
Purpose Detection rates of depression in obstetric care
are generally low, and many women remain undiagnosed
and do not receive adequate support. In many obstetric
settings, screening tools for depression are not applied
routinely and there is a great need to sensitize health care
professionals for the patient at risk for enhanced levels of
depression. The present study aimed at identifying com-
monly assessed patient characteristics that are associated
with antenatal depression.
Methods One hundred and thirty seven women were
screened using the Edinburgh Postnatal Depression Scale
(EPDS) at the beginning of the second trimester at the
outpatient department of a Tertiary University Hospital.
Women were identified as at high risk for depression if
scores were above a cut-off score of twelve. Obstetric
history and outcome were extracted from patient files after
delivery.
Results Twenty one percent of the sample screened as
depression positive. Logistic regression with backwards
elimination showed that the triad of nausea during
pregnancy, reports of (premature) contractions and
consumption of analgesics during pregnancy significantly
predicted high depression scores with a positive predictive
value of 84.3%. The relative risk for a depressed pregnant
woman to regularly take analgesics during pregnancy was
fourfold higher than for non-depressed women.
Conclusions If depression screening is not part of routine
prenatal care, systematic assessment of depression should
be targeted for patients presenting with the markers iden-
tified in this study.
Keywords Antenatal depression  Screening 
Patient characteristics  Nausea  Analgesics
Introduction
While in the context of reproduction for many years, the
focus has been on postnatal depression, studies of the past
decade have shown that the incidence of postnatal
depression is lower than expected and that the majority of
cases of postnatal depression are preceded by antenatal
depression [1]. A recent meta-analysis [2] of 21 studies on
the prevalence of depression during pregnancy differenti-
ates between questionnaire-based studies and studies that
determine the prevalence of depression by structured
interviews. The overall rate of depression was 7.4, 12.8 and
12% for each trimester, respectively, with comparable
numbers that have been found for Switzerland [3]. The
prevalence rates detected with structured interviews or the
Edinburgh postnatal depression scale (EPDS) [4] did not
differ significantly.
Despite the fact that according to these numbers, at least
every tenth pregnant woman presenting for regular
checkups during pregnancy will be depressed, especially
during pregnancy, detection rates of depressive illness are
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low: only 26% of patients who screened positive for a
psychiatric illness was recognized as having a mood or
anxiety disorder and detection rate for depressive disorders
was even lower [5] which is comparable to other non-
psychiatric medical disciplines [6]. As Kammerer et al. [3]
point out, it has been disregarded how gestation-associated
physiological and psychosocial changes may confound the
diagnosis of depression and thus contribute to the low
detection rates in prenatal care. In addition, clinicians
generally do not address mood states at prenatal visits. The
legitimate focus of attention in antenatal care lies on the
optimal course of pregnancy, physical wellbeing of the
pregnant woman and foetal condition. However, with many
recent studies pointing to a negative impact of antenatal
mental health problems on course of pregnancy, foetal and
neonatal outcome (for review see [7]), the assessment of
psychological state becomes relevant for obstetric care as
well. In addition, independent of its influence on outcome,
depression is associated with negative health behaviour [8]
and adversely affects the mother’s functional state and
quality of life, and is a relevant illness which needs to be
treated appropriately.
Depression during pregnancy has been associated with
obstetric complications, and adverse foetal and neonatal
parameters of wellbeing. Depressed women report more
somatic symptoms, have more visits to the obstetrician, and
receive more pain relief during labour [9–13]. While a
global score of obstetric complications appears to be
enhanced in depressed patients [14], there is still contro-
versy about the impact of depression on the development of
specific pregnancy associated diseases such as pre-
eclampsia [10, 15, 16]. In addition, controversies exist on
the effect of depressive symptoms on mode of delivery [10,
12, 17, 18]. Moreover, foetuses of depressed mothers seem
to be more active in general and more reactive to a stan-
dardized maternal stress condition [14, 19–21]. In addition,
a negative impact of antenatal depression on birth weight
and gestational age with some controversies [22–26], and
higher admission rates to Neonatal Intensive Care Unit
NICU [12, 27] have been reported.
These results point to the importance of an early
detection of women with an enhanced risk for depression.
These assessments may take the form of a brief ques-
tionnaire or a structured psychosocial interview. The
EPDS is the most widely accepted screening scale, has
been translated into different languages, and is used
internationally in the perinatal period. While having been
developed to screen for postnatal depression in the pri-
mary care setting, validation studies have shown its
suitability to screen for depression in the antenatal period
as well [28, 29]. Although it appears simple to use,
training in administering and scoring the scale, giving
women appropriate feedback, and understanding its
limitations are important. Several concerns have been
discussed for the implementation of screening programs
in antenatal care such as false positive and false negative
results and the corresponding consequences for the preg-
nant women and the health care professionals, the risk of
stigmatization or the lack of treatment resources when
depression is confirmed. However, as Buist et al. [30]
point out, the alternative of not identifying distressed
women is not satisfactory either and it is better to identify
distress and attempt to deal with it as optimal as possible
than to deny its existence and suffer the potential long-
term consequences. Yet, the implementation of systematic
screening in clinical routine is often jeopardized by
institutional and intrapersonal factors such as time con-
straints, limited personnel or lack of skills. In this context,
it may be essential to sensitize health care professionals to
characteristics of pregnant women at risk for antenatal
distress and enhance their skills in identifying those
women where the application of a screening questionnaire
is suggestive. As suggested by Jesse and Graham [31] one
or two questions can be used to decide, whether the
application of a screening tool can be reasonable.
Another approach is by identifying socio-demographic
factors which are known to be associated with antenatal
depression. Some perinatal studies have identified
younger age, lower socioeconomic status, lower levels of
education [26, 32], belonging to a minority group [5, 33]
and not being married [32, 34] to be associated with
states of depression, while others have not found some of
these associations [3, 26, 35]. In addition, some studies
point to differences in antenatal care between women
with high levels of depression and healthy women with
more patient complaints on somatic symptoms, mostly
abdominal pain [13] and more prescriptions of antibiotics
for the depressed [32]. Not much is known on other
factors which belong to routine clinical assessment during
antenatal care and their association to levels of
depression.
While obstetricians are not trained often to systemati-
cally assess psychological symptoms during pregnancy by
use of specific questions or validated questionnaires, the
recognition of specific characteristics of depressed preg-
nant women can facilitate the identification of women with
enhanced levels of depression in antenatal care.
Therefore, the aim of this study is to detect a profile of
depressed pregnant women considering medical informa-
tion and patient characteristics which are routinely being
assessed during antenatal care. For this purpose, women
with enhanced levels of depression according to the EPDS
will be compared to asymptomatic women with regard to
regularly assessed clinical characteristics in order to iden-
tify those factors which are predictive for antenatal
depressive symptoms.
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Methods
Study population
The present retrospective case–control study is part of a
placebo-controlled trial on the effectiveness of light ther-
apy for the treatment of antenatal depression. German-
speaking women attending routine pregnancy care at the
beginning of the second trimester at University Women’s
Hospital of Basel, Switzerland, after being informed and
consenting to participation, were screened for depression.
Patients with depression scores [12 in the Edinburgh
Postnatal Depression Scale (EPDS) according to the Ger-
man validation of the questionnaire [36] are identified as
probable cases of depression (index group) and are com-
pared to the group of pregnant women with scores below
the cut-off score (controls). During the consultation, the
obstetrician referred to the results of the EPDS and dis-
cussed with high scoring patients the subsequent proce-
dures. If the patient agreed, she was referred to the light
therapy study, where depression was confirmed by struc-
tured clinical interview (SCID). The present data analysis
includes results from this screening procedure. To guar-
antee a high and comparable standard of data quality
between depressed and non-depressed patients, we only
considered records of women, who had all pregnancy
controls starting from the first trimester to delivery at the
clinic. In total, 137 patients were enrolled.
Measures
Edinburgh postnatal depression scale (EPDS)
Symptoms of depression were assessed by the EPDS [4,
36], a 10-item screening tool providing an indication of
symptom severity. Items are rated on a four-point Likert
scale. The EPDS is the only screening tool for validating
depression also for the perinatal period. To identify women
with probable major depression in the postpartum a cut-off
score of 13 or more has been found useful across various
studies, while the use of a score of 10 or more has been
recommended to identify women at risk of postnatal minor
depression or increase in the sensitivity [29]. For the
detection of patients at risk of fulfilling the criteria of major
depression during pregnancy, a higher score of 15 or more
and for those with risk of antenatal minor depression a
score of 13 or more has been recommended based upon
published validation studies [29]. For the present analysis
we decided to evaluate clinical characteristics of women
with enhanced levels of depression and not only those at
risk for major depression, and therefore used the cut-off
score of 13 or more. The identification of these women
during antenatal care and provision of support might not
only prevent the exacerbation of their depressive symptoms
but also might be beneficial for obstetric and neonatal
outcome.
Pregnancy data
Information on course of pregnancy, complications,
delivery and neonatal outcome were extracted from patient
records and birth reports.
To identify a profile of depression during pregnancy, the
following background variables were selected: age, parity,
pre-pregnancy BMI, intake of medication during preg-
nancy, smoking, provenience, and subjectively reported
contractions. These variables were chosen because they are
part of standard history taking during prenatal checkups,
while during prenatal care very often information on other
risk factors such as family affective disorder history, past
psychiatric history, current levels of stress and resources
such as social support are not assessed.
Statistical analysis
Using logistic regression analysis, we determined the
impact of the selected background variables on the
dependent variable high depression scores (defined as
EPDS-score [12). The variables age, parity, origin (cate-
gorical: (1) Northern and Western Europe, North America
and (2) Southern, Eastern Europe, South America, Africa,
Asia), pre-pregnancy BMI, patient reports of premature
contractions before pregnancy week 37 (categorical: yes/
no), nausea (categorical: yes/no), smoking (categorical:
yes/no) and consumption of medication entered as candi-
date predictors. Backward elimination was conducted with
probability of inclusion set at 0.05 and exclusion set at
0.10. Consumption of medication was categorized as none,
analgesics and other and no consumption of medication
served as the reference for the latter two. The overall model
fit was tested with the likelihood ratio test, and Nage-
lkerke’s R2 statistics are reported as well considering the
rather low number of depressed patients. Percentage of
overall correct predictions and specificity and sensitivity
values for the predictors remaining in the model were
calculated. Data were analysed using SPSS 16.
Results
Table 1 displays main characteristics of the studied sample
and compares women with EDPS scores of 13 or more to
those with lower scores on socio-demographic variables.
Mean age of patients was 30 years and mean parity was
1.64, reflecting the average number of children/woman in
Switzerland. There were no differences between women
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who scored 13 or above with regard to age, parity, and birth
weight, however there was a tendency for longer gestations
in this group (40.2 vs. 39.6 weeks) and for having a
migration background. As shown in Table 2, women with
an EPDS cut-off score of 13 or above differed significantly
with regard to several study variables. They reported more
premature contractions, more nausea during pregnancy and
a higher intake of medication and, more specifically,
analgesics. In contrast to many other studies on the asso-
ciation of depressive symptoms and unhealthier life style,
the high scorers in this group did not differ with regard to
smoking behaviour and BMI.
In Table 3, the results of the logistic regression analysis
for the identification of patient characteristics predictive for
depression are shown. In a first step, all of the variables
were included and premature contractions (OR = 4.2,
p \ 0.05), nausea (OR = 3.7, p \ 0.05) and analgesics
(OR = 8.4, p \ 0.01) resulted to be predictive for EPDS
scores of 13 or more. These three variables report of pre-
mature contractions, nausea, and intake of analgesics
remained in the final model, which resulted highly signif-
icant (v2 = 30.87, df = 4, p \ 0.001) with a Nagelkerke’s
R2 = 0.38. The total amount of correct predictions of
depression for the three variables reported premature con-
tractions, nausea and consumption of analgesics was
84.3%, with a specificity of 0.95 and sensitivity of 0.44.
The relative risk (RR) for patients with depression scores
above the EPDS score of 12 to report premature contrac-
tions was RR = 2.44, to suffer from nausea or vomiting
RR = 1.75 and to consume analgesics during pregnancy
was RR = 4.30.
Discussion
Using an EPDS-cut-off score of 13 or more we found
enhanced levels of depression in 21.1% of our sample.
While being indicative for the presence of a minor
depression, we found scores of 15 and above in 10.9% of
the study population. Thus, the observed rate of probable
major depression is comparable to other studies [27],
while, in line with other data, minor depression affected
about every fifth pregnant woman [37]. With the growing
evidence that clinical and subclinical antenatal depression
negatively affects the course of pregnancy, foetal devel-
opment and neonatal adaptation [7], there is a great need to
identify women at risk. As there are still only a few
countries and health care systems which have introduced
screening for depression in standard obstetric care, it is
important to sensitize health care professionals to probable
signs of antenatal depression. The present study, therefore
aimed at the evaluation of variables which are part of
standard obstetric history taking in most settings, and at
investigating their association to antenatal depression.
Including socio-demographic and obstetric parameters,
those variables which correctly identified 84.3% of the
women with an EPDS score of 13 or more, were subjective
report of premature contractions, nausea and consumption
of analgesics with the latter being associated with a four-
fold enhanced relative risk for depression. Age, parity,
health behaviour such as smoking and BMI and having a
migration background were not related to antenatal
depression. The sample of our present study, however,
included only German speaking women. Therefore,
Table 1 Socio-demographic
characteristics of the total
sample and women with high
and low EPDS scores
? p \ 0.1
a Reported as mean (SD)
b Reported as number (%)
Total EPDS 13 or more EPDS below 13
Agea 30.11 (6.22) 29.86 (6.51) 30.18 (6.17)
Paritya 1.64 (0.74) 1.66 (0.72) 1.64 (0.74)
Weight of childa (g) 3,312.66 (492.05) 3,359.81(464.24) 3,299.90 (500.85)
Length of gestationa 39.59 (1.78) 40.20 (1.08) 39.43 (1.895)?
Migration backgroundb 55 (40.1) 16 (55.2) 39 (36.1)?
Table 2 Comparison of woman
with high and low EPDS sum
scores
** p \ 0.01
a Reported as number (%)
b Reported as mean (SD)
Total EPDS 13 or more EPDS below 13
Subjectively reported premature contractionsa 46 (33.6) 18 (72) 29 (26.9)**
Smoking during pregnancya 37 (27) 9 (33.3) 28 (26.2)
Reported nausea/vomitinga 71 (51.8) 22 (81.5) 49 (45.4)**
Medication during pregnancya 60 (43.8) 19 (65.5) 41 (38)**
Analgesicsa 26 (19) 14 (48.3) 12 (11.1)**
Prepregnancy BMIa (kg/m2) 23.09 (4.83) 22.34 (2.46) 23.33 (5.36)
EPDS sum scoreb 7.12 (5.76) 15.97 (3.17) 4.75 (3.56)**
EPDS [ 15a 15 (10.9)
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especially those migrant women with a high degree of
stress due to socioeconomic concerns such as acculturation
problems, higher unemployment rates and for whom dif-
ferences in pregnancy outcome have been reported before
[38], did not participate in the study. The finding that the
other demographic factors were not associated with higher
rates of depression, contrasts with some studies who have
found higher levels of depression in younger women and
women from minority groups [5, 27, 32]. On the other
hand, our results are in line with data from other groups
who have found more complaints about abdominal pain in
the depressed [13]. The psychosomatic nature of the
depression-associated factors in the current study points to
a high degree of somatization of depression during preg-
nancy or its presentation with somatic symptoms and is in
support of other findings [13, 39]. It is, in addition, a
finding with important clinical implications as the presen-
tation of somatic symptoms may mask the underlying
symptoms of depressions and lead to inadequate interven-
tions. Prenatal depression therefore often presents as a
‘‘silent’’ form of depression, it may be difficult to differ-
entiate the depressive symptoms from general mood swings
due to hormonal alterations and complaints about preg-
nancy-associated physical changes. However, as shown by
the results of this study, practitioners must be aware of a
possible overlap of general complaints and depressive
symptoms, as prenatal depression, can have adverse effects
if left untreated.
Also, it remains to be determined, if in depressed
pregnant women the processing of proprioceptive signals
itself or the cognitive attribution of perceived signals are
altered and thus depressogenic.
The specificity of the correlates of antenatal depression
found in this study is high, therefore being a reliable way to
identify those pregnant women with a chance of being
depressed. However, the sensitivity is too low in order to
only rely on the identified correlates considering that more
than half of the truly depressed patients will not be iden-
tified. The findings thus indicate that the probability of
depression is high if a woman presents with nausea reports
of premature contractions and intake of analgesics; how-
ever, depression can also be present without these
symptoms.
Optimally, screening for depression should therefore be
implemented in routine prenatal care and it has been shown
that it is well accepted in this population [40]. As stated by
the American College of Obstetricians and Gynecologists
ACOG, screening should also include depression-associ-
ated risk factors, such as lower use of health care, housing
problems, violence and inadequate health behaviours [41].
Also, there is general consensus that screening for
depression in prenatal care should be delivered systemati-
cally including predefined referral pathways as it is unli-
kely that antenatal psychosocial assessment alone already
leads to improved mental health outcomes [42]. An inter-
disciplinary approach and communication training for staff
members are additional features of successful screening
concepts [41, 43]. Communication skills to sensitively
address the psychological state of a pregnant woman are
especially important in systems without implemented
screening. As such, pregnant women conspicuous with the
symptoms found in the present study need to be sensitively
questioned about their psychological wellbeing, asking for
general wellbeing, current stressors and concerns and pre-
existing or recent mood swings and sadness.
Alternatively, the two screening questions, ‘‘Have you
lately often been sad and depressed’’ and ‘‘Have you had a
loss in pleasurable activities’’, have shown a sensitivity of
92% and specificity of 52% to identify patients suffering
from depression during pregnancy [31].
Several limitations of the present study need to be dis-
cussed. Besides modest sample size, at the time of the
study the EPDS was only available to us in German. Thus,
an important risk group, women who recently migrated to
Switzerland without sufficient language skills, were not
included. In addition, while during the observation period
all women who presented for routine checkup at gestational
Table 3 Logistic regression analysis with backwards elimination on
background variables predicting high levels of depression (first and
final step after backwards elimination)
B OR CI
First step
Age 0.04 1.04 0.93–1.17
Migration background 0.64 1.9 0.51–7.10
Parity -0.47 0.62 0.23–1.69
BMI -0.09 0.91 0.76–1.09
Smoking 0.48 1.62 0.43–6.09
Premature contractions 1.25 3.49 1.09–11.22*
Nausea 1.24 3.47 0.96–12.53?
Medication
No Reference
Analgesics 2.09 8.12 1.70–38.834**
Other medication -0.34 0.72 0.17–3.06
Final step
Premature contractions 1.28 3.61 1.17–11.08*
Nausea 1.21 3.34 0.98–11.39?
Medication
No Reference
Analgesics 1.91 6.73 1.59–12.54**
Other medication -0.34 0.71 0.17–2.93
? p \ 0.1
* p \ 0.05
** p \ 0.01
Arch Gynecol Obstet (2011) 284:1403–1409 1407
123
week 15 were asked to participate, some women were not
included due to time constraints by the staff. Also, women
who presented later or had their checkups outside of the
hospital were not included either. Thus, while the results
cannot be generalized, the validity of the obstetric infor-
mation is good and comparable within the study popula-
tion. Nevertheless, the information assessed during routine
prenatal care did not include other factors known to be
associated to antenatal depression such as socioeconomic
status or the previous history of psychopathology. While
being a limitation for comprehensive psychosocial assess-
ment, it still reflects the clinical reality of many prenatal
care services.
Conclusions
From the current literature and present study, the following
conclusions can be drawn. Health care providers, specifi-
cally those in obstetric care, should be aware of (1) the
frequency of depression in pregnant women. Being as
prevalent as in non-pregnant state, prenatal depression is
under recognized in prenatal care [5] and there is a great
need to sensitize obstetricians for the recognition of
patients with depression during pregnancy. (2) Obstetri-
cians should be aware of signs and symptoms of depression
and appropriate screening methods. If depression screening
cannot be implemented in the obstetric routine, pregnant
women presenting with the triad nausea, contractions and
consumption of analgesics should be carefully screened
and history and current levels of depression should be
assessed unconditionally. (3) The health risks of undetected
and untreated depression for the mother and growing foetus
are considerable. For example, depression is associated
with elevated risk for preterm delivery, low birth weight
and intrauterine growth retardation comparable to other
obstetric risk factors, which are controlled for as part of
standard routine care (e.g., blood pressure, proteinuria)
[44]. The awareness of these associations might improve
adherence to screening for depression in prenatal care.
Conflict of interest None.
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